Association between airflow limitation severity and reduced bone mineral density in Japanese men

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2018 Available from: http://www.goldcopd.com/ Accessed 79, 2018.
   Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• Available from: http://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 82, 2018.
   Google Scholar
• Available from: http://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death Accessed 82, 2018.
   Google Scholar
• Japanese Respiratory Society. The JRS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. 5th ed. Tokyo:  Medical Review Co., Ltd; 2018.
   Google Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.0001240818579551
   PubMed Web of Science ®Google Scholar
• Decramer M, Rennard S, Troosters T, et al. COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD. 2008;5(4):235–256. doi:10.1080/1541255080223753118671149
   PubMedGoogle Scholar
• Divo M, Cote C, de Torres JP, BODE Collaborative Group, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC.22561964
   PubMed Web of Science ®Google Scholar
• Gershon AS, Mecredy GC, Guan J, Victor JC, Goldstein R, To T. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J. 2015;45(1):51–59. doi:10.1183/09031936.0006141425142481
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.0013380517138679
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-928513453
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212. doi:10.1183/09031936.0011430718166598
   PubMed Web of Science ®Google Scholar
• Lehouck A, Boonen S, Decramer M, Janssens W. COPD, bone metabolism, and osteoporosis. Chest. 2011;139(3):648–657. doi:10.1378/chest.10-142721362651
   PubMed Web of Science ®Google Scholar
• Sarkar M, Bhardwaj R, Madabhavi I, Khatana J. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;12(9):5–21.
   Google Scholar
• Jørgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease - a cross sectional study. Respir Med. 2007;101(1):177–185. doi:10.1016/j.rmed.2006.03.02916677808
   PubMed Web of Science ®Google Scholar
• Majumdar SR, Villa-Roel C, Lyons KJ, Rowe BH. Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respir Med. 2010;104(2):260–266. doi:10.1016/j.rmed.2009.09.01319828305
   PubMed Web of Science ®Google Scholar
• Duckers JM, Evans BA, Fraser WD, Stone MD, Bolton CE, Shale DJ. Low bone mineral density in men with chronic obstructive pulmonary disease. Respir Res. 2011;3(12):101. doi:10.1186/1465-9921-12-101
   Web of Science ®Google Scholar
• Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2011;26(3):561–568. doi:10.1002/jbmr.25720878771
   PubMed Web of Science ®Google Scholar
• Nuti R, Siviero P, Maggi S, et al. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int. 2009;20(6):989–998. doi:10.1007/s00198-008-0770-418931817
   PubMed Web of Science ®Google Scholar
• Sakurai-Iesato Y, Kawata N, Tada Y, et al. The relationship of bone mineral density in men with chronic obstructive pulmonary disease classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Combined Chronic Obstructive Pulmonary Disease (COPD) assessment system. Intern Med. 2017;56(14):1781–1790. doi:10.2169/internalmedicine.56.691028717072
   PubMed Web of Science ®Google Scholar
• de Luise C, Brimacombe M, Pedersen L, Sørensen HT. Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol. 2008;23(2):115–122. doi:10.1007/s10654-007-9211-518038248
   PubMed Web of Science ®Google Scholar
• Lewis B, Tricia M, Jessica N, et al. Outcomes post hip fracture for patients with COPD. Eur Respir J. 2018;52(Suppl. 62):PA4145. doi:10.1183/13993003.01675-2018
   Web of Science ®Google Scholar
• Moayyeri A, Bingham SA, Luben RN, Wareham NJ, Khaw K-T. Respiratory function as a marker of bone health and fracture risk in an older population. J Bone Miner Res. 2009;24(5):956–963. doi:10.1359/jbmr.08123119402201
   PubMed Web of Science ®Google Scholar
• Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int. 2007;18(9):1197–1202. doi:10.1007/s00198-007-0355-717347789
   PubMed Web of Science ®Google Scholar
• Watanabe R, Tanaka T, Aita K. et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2015;33(4):392–400. doi:10.1007/s00774-014-0605-724996527
   PubMed Web of Science ®Google Scholar
• Omori H, Nagano M, Funakoshi Y. et al. Twelve-year cumulative incidence of airflow obstruction among Japanese males. Intern Med. 2011;50(15):1537–1544. doi:10.2169/internalmedicine.50.441221804278
   PubMed Web of Science ®Google Scholar
• Oda M, Omori H, Onoue A. et al. Association between airflow limitation severity and arterial stiffness as determined by the brachial-ankle pulse wave velocity: a cross-sectional study. Intern Med. 2015;54(20):2569–2575. doi:10.2169/internalmedicine.54.377826466690
   PubMed Web of Science ®Google Scholar
• Onoue A, Omori H, Katoh T, et al. Relationship of airflow limitation severity with work productivity reduction and sick leave in a Japanese working population. Int J Chron Obstruct Pulmon Dis. 2016;11:567–575. doi:10.2147/COPD.S9978627042045
   PubMed Web of Science ®Google Scholar
• Omori H, Tsuji M, Sata K, et al. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema. Respirology. 2009;14(4):551–558. doi:10.1111/j.1440-1843.2009.01519.x19386068
   PubMed Web of Science ®Google Scholar
• Masuda S, Omori H, Onoue A, et al. Comorbidities according to airflow limitation severity: data from comprehensive health examination in Japan. Environ Health and Prev Med. 2017;22(1):13. doi:10.1186/s12199-017-0620-029165119
   PubMed Web of Science ®Google Scholar
• Omori H, Kaise T, Suzuki T, et al. Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: survey of chronic obstructive pulmonary disease patients epidemiology in Japan. Int J Chron Obstruct Pulmon Dis. 2016;11:873–880. doi:10.2147/COPD.S9993527217740
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• Japanese Respiratory Society. Reference values for spirometry in Japanese adult [Internet]. Available from: http://www.jrs.or.jp/modules/guidelines/index.php?content_id=12 Accessed 82, 2018.
   Google Scholar
• WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and Management of Osteoporosis: report of a WHO scientific group. WHO technical report series; 920. Geneva: World Health Organization; 2003.
   Google Scholar
• Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114(1):10–14. doi:10.1016/s0002-9343(02)01297-412543283
   PubMed Web of Science ®Google Scholar
• Herland T, Apalset EM, Eide GE, Tell GS, Lehmann S. Airflow limitation as a risk factor for low bone mineral density and hip fracture. Eur Clin Respir J. 2016;3:32214 eCollection 2016. doi:10.3402/ecrj.v3.3221427733234
   PubMed Web of Science ®Google Scholar
• Miyamoto RG, Kaplan KM, Levine BR, Egol KA, Zuckerman JD. Surgical management of hip fractures: an evidence-based review of the literature. I: femoral neck fractures. J Am Acad Orthop Surg. 2008;16(10):596–607.18832603
   PubMed Web of Science ®Google Scholar
• Farahmand BY, Michaëlsson K, Ahlbom A, Ljunghall S, Baron JA. Survival after hip fracture. Osteoporos Int. 2005;16(12):1583–1590. doi:10.1007/s00198-005-2024-z16217590
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA, Odén A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38–42. doi:10.1007/s00198-003-1490-414593451
   PubMed Web of Science ®Google Scholar
• Kjensli A, Mowinckel P, Ryg MS, Falch JA. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007;40(2):493–497. doi:10.1016/j.bone.2006.09.00517049326
   PubMed Web of Science ®Google Scholar
• Dennison EM, Dhanwal DK, Shaheen SO, et al. Is lung function associated with bone mineral density? Results from the Hertfordshire Cohort Study. Arch Osteoporos. 2013;8:115. doi:10.1007/s11657-012-0115-y23322029
   PubMed Web of Science ®Google Scholar
• Jaramillo JD, Wilson C, Stinson DS, et al. Reduced bone density and vertebral fractures in smokers. Men and COPD patients at increased risk. Ann Am Thorac Soc. 2015;12(5):648–656. doi:10.1513/AnnalsATS.201412-591OC25719895
   PubMed Web of Science ®Google Scholar
• de Pablo P, Cooper MS, Buckley CD, et al. Association between bone mineral density and C-reactive protein in a large population-based sample. Arthritis Rheum. 2012;64(8):2624–2631. doi:10.1002/art.3447422487938
   PubMed Web of Science ®Google Scholar
• Samaria JK, Bhatia M. Raised CRP levels associated with osteoporosis in patients with COPD. Am J Respir Crit Care Med. 2015;191:5716.
   Google Scholar
• Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65(3):215–220. doi:10.1136/thx.2009.12065919996341
   PubMed Web of Science ®Google Scholar
• Førli L, Halse J, Haug E, et al. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med. 2004;256(1):56–62. doi:10.1111/j.1365-2796.2004.01337.x15189366
   PubMed Web of Science ®Google Scholar
• Romme EA, Rutten EP, Smeenk FW, et al. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med. 2013;45(1):91–96. doi:10.3109/07853890.2012.67153622462562
   PubMed Web of Science ®Google Scholar